As many as 12% of Americans are currently using GLP-1 medications such as Ozempic and Wegovy, according to one estimate.

With weight loss drugs taking the world by storm, more people are exploring adding these medical marvels to their toolkits.

Clinical trials show retatrutide, Eli Lilly's new triple-agonist drug, delivered 24.2% weight loss in 48 weeks and the ...

GLP-1 weight-loss pills appear to be just as effective as injections, with clinical trials showing similar average weight ...

Discontinuing obesity medicines often means the weight comes back and people lose the cardiovascular and metabolic benefits ...

Everything from AI-generated videos of celebrities to fake online pharmacies are being used to try to dupe consumers ...

Conagra Brands added a “GLP-1 Friendly” label to 26 of its Healthy Choice frozen meals in early 2025. The Smoothie King chain ...

Microdosing GLP-1 weight loss drugs like semaglutide is trendy, with supporters touting benefits such as lower costs and potentially fewer side effects. But some doctors are skeptical, calling it ...

The Wegovy pill comes in tablet form—and is the first U.S. Food & Drug Administration (FDA)-approved GLP-1 to do so. Its ...

There’s no sign of GLP-1s slowing down anytime soon, especially now that they have the support of top-notch athletes.

Retailer offerings trumpet a variety of claims about protein, fat and fibre levels, while some seem to simply be smaller ...

The GLP-1 moment signals how quickly a high-demand therapy can upend established care patterns—and how similar innovations ...